Drugs / neutral protamine Hagedorn
last change Apr 2013 re-read 2 minutes ago

neutral protamine Hagedorn

also known as NPH
Developed for
type 2 diabetes mellitus

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00174668 Comparator Nov 2004 → Nov 2007 type 2 diabetes mellitus Sanofi Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as neutral protamine Hagedorn “which consisted of two subgroups receiving either neutral protamine Hagedorn (NPH) plus regular insulin (n=93) or biphasic insulin aspart 70/30 (n=63)” PMID 30349602 Apr 2013
Known as NPH NPH (70%) plus regular insulin or insulin aspart (30%)” NCT00174668